• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Molina Healthcare Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    11/14/25 4:15:54 PM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email
    moh20251114_8k.htm
    false 0001179929 0001179929 2025-11-14 2025-11-14
     


     
    UNITED STATES
     
    SECURITIES AND EXCHANGE COMMISSION
     
    Washington, D.C. 20549
     

     
    FORM 8-K
     

     
    Current Report
     
    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): November 14, 2025
     

     
    MOLINA HEALTHCARE, INC.
    (Exact name of registrant as specified in its charter)
     
    Delaware
    1-31719
    13-4204626
    (State or other jurisdiction of
    incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)
     

     
    200 Oceangate, Suite 100, Long Beach, California
    90802
    (Address of principal executive offices)
    (Zip Code)
     
     
    Registrant’s telephone number, including area code: (562) 435-3666
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock, $0.001 Par Value
    MOH
    New York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                                     
    ☐
     


     
     

     
     
    Item 7.01. Regulation FD Disclosure.
     
    On November 14, 2025, Molina Healthcare, Inc. (“Molina” or the “Company”) announced that the Florida Agency for Health Care Administration (AHCA) has issued a Notice of Agency Decision that it intends to award Molina Healthcare of Florida a contract to provide Statewide Medicaid Managed Care (SMMC) Program and Children’s Health Insurance Program (CHIP) services to enrollees of the Title XIX and Title XXI Children’s Medical Services (CMS) Program. The full text of the press release is included as Exhibit 99.1 to this report and incorporated by reference herein.
     
    Note: The information in this Form 8-K and the exhibits attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
     
     
    Item 9.01.    Financial Statements and Exhibits.
     
    (d)     Exhibits:
     
    Exhibit No.
    Description
    99.1
    Press release of Molina Healthcare, Inc., issued November 14, 2025
       
    104
    Cover Page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on November 14, 2025 formatted in iXBRL (Inline Extensible Business Reporting Language)
     
     

     
     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    MOLINA HEALTHCARE, INC.
       
    Date:        November 14, 2025
    By:
    /s/ Jeff D. Barlow
       
    Jeff D. Barlow
       
    Chief Legal Officer and Secretary
     
     
    Get the next $MOH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    10/24/2025$144.00Equal Weight → Underweight
    Barclays
    10/16/2025$203.00Buy → Hold
    TD Cowen
    10/14/2025$207.00Neutral
    Goldman
    7/25/2025$210.00Overweight → Neutral
    Cantor Fitzgerald
    7/25/2025$180.00Buy → Hold
    Truist
    7/10/2025$266.00Overweight → Equal-Weight
    Morgan Stanley
    6/9/2025$364.00Overweight
    Morgan Stanley
    4/22/2025$414.00Outperform
    Bernstein
    More analyst ratings

    $MOH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Woys James bought $1,559,365 worth of shares (10,000 units at $155.94), increasing direct ownership by 16% to 74,331 units (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    8/6/25 4:47:39 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    SEC Filings

    View All

    Molina Healthcare Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/20/25 4:27:59 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/17/25 8:25:40 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

    11/14/25 4:15:54 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.500% per annum. Interest on the Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing August 15, 2026 and a

    11/20/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 20, 2025 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any

    11/17/25 6:10:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031

    Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will offer the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Com

    11/17/25 8:20:00 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Molina Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Molina Healthcare from Equal Weight to Underweight and set a new price target of $144.00

    10/24/25 8:58:34 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare downgraded by TD Cowen with a new price target

    TD Cowen downgraded Molina Healthcare from Buy to Hold and set a new price target of $203.00

    10/16/25 8:20:06 AM ET
    $MOH
    Medical Specialities
    Health Care

    Goldman initiated coverage on Molina Healthcare with a new price target

    Goldman initiated coverage of Molina Healthcare with a rating of Neutral and set a new price target of $207.00

    10/14/25 8:50:43 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zoretic Richard C was granted 285 shares (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    10/2/25 8:08:55 PM ET
    $MOH
    Medical Specialities
    Health Care

    Director Wolf Dale B was granted 285 shares (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    10/2/25 8:08:03 PM ET
    $MOH
    Medical Specialities
    Health Care

    Director Schapiro Richard M was granted 285 shares, increasing direct ownership by 2% to 11,709 units (SEC Form 4)

    4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

    10/2/25 8:05:49 PM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

    SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/14/24 1:22:34 PM ET
    $MOH
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Molina Healthcare Inc

    SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/12/24 12:53:29 PM ET
    $MOH
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

    SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

    11/8/24 10:34:33 AM ET
    $MOH
    Medical Specialities
    Health Care

    $MOH
    Financials

    Live finance-specific insights

    View All

    Molina Healthcare Reports Third Quarter 2025 Financial Results

    Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below:   Three months ended   Nine months ended   September 30,   September 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $ 10,841     $ 9,694     $ 32,337    

    10/22/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Announces Third Quarter 2025 Earnings Release and Conference Call Dates

    Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2025, after the market closes on Wednesday, October 22, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 2660919. A telephonic replay of the conference call will be available through Thursday, October 30, 2025, by dialing (877) 344-7529 and entering the confirmation number, 1905016. A live broadcast of Molina Healthcare's conference call will be available on the Company's inve

    9/3/25 9:00:00 AM ET
    $MOH
    Medical Specialities
    Health Care

    Molina Healthcare Reports Second Quarter 2025 Financial Results

    Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

    7/23/25 4:15:00 PM ET
    $MOH
    Medical Specialities
    Health Care